Metabolic evaluation of high-risk stone formers: a retrospective study
African Journal of Urology volume 29, Article number: 6 (2023)
The purpose of this study was to assess the metabolic abnormalities in high-risk stone formers.
This was a retrospective observational study done at Tribhuvan University Teaching Hospital, Nepal, over 1-year period. High-risk stone formers were identified and were evaluated with serum chemistries and 24-h urinary chemical evaluation. Stone analysis was also included whenever available. Common metabolic abnormalities and stone analysis results were reported and compared with different studies. Continuous variables were expressed as mean ± SD. Categorical variables were expressed as percentage and proportions.
During 1 year of period, sixty-five patients had undergone extensive metabolic evaluation, but complete data were available for only forty-six patients. Of the total patients (n = 46), 63% were male (n = 29) and rest (36.9%) were female. Mean age of patients was 34.4 ± 15.1 years. Common reasons for metabolic evaluation were multiple stones (40%), bilateral stones (27%), recurrent stones (17%) and others (16%). Most common stone type was mixed stone with predominant composition being calcium oxalate mono- and dihydrate (62.9%). Twenty-four-hour urinary metabolic evaluation showed hyperoxaluria (32.6%) as most common abnormalities followed by hypocitraturia (21.7%) and hypocalciuria (21.7%).
Hyperoxaluria and hypocitraturia are common metabolic abnormalities in our patients. These findings help in counselling dietary measures to patients.
Urinary tract stones are known to recur over years and may be manifestation of underlying systemic disease [1,2,3,4,5]. Identification of responsible factors of stone formation and timely initiation of preventive measures is necessary duty of a practicing urologist. Several studies have shown variable rate of stone recurrence ranging from 30 to 75% over 5–10 year’s duration [1, 2].
Metabolic evaluation of stone formers helps to identify the physiological basis of stone formation. Ideally it should be cheap, simple and applicable for clinical practice . Common metabolic problems include but are not limited to distal renal tubular acidosis (RTA), primary hyperparathyroidism, enteric hyperoxaluria and gouty diathesis. These conditions need to be identified and treated to prevent recurrent stones and to correct physiological disturbances leading to non-renal complications [7, 8].
Current American Urological Associations (AUA) guidelines suggest that physician can perform metabolic evaluation in high-risk stone formers or interested first stone formers . This evaluation is a shared decision between physician and patient. High-risk individuals are those with obesity, metabolic syndrome, family history of stone disease and with medical conditions such as hyperparathyroidism, gout, renal tubular acidosis, type 2 diabetes mellitus, urinary tract infection, sarcoidosis, gastrointestinal diseases and intestinal resection surgery [9,10,11]. Similarly, children are the another important group of patients requiring full metabolic evaluation as abnormalities are common [12, 13]. Cost is one of the factor which need to be considered while planning metabolic evaluation. Some studies have reported that metabolic evaluation is only cost effective in high-risk and recurrent stone formers compared to first time stone formers [14, 15]. Commonly detected metabolic abnormalities are hypercalciuria, hypocitraturia, hyperoxaluria with different proportions in different studies [16,17,18,19,20].
South-Asian countries have different geographic location, dietary habits and genetic differences compared to western countries. Recurrent stone formers are commonly encountered in clinical practice; however, studies are not published from our country. We aim to study our patients regarding their metabolic abnormalities.
This was an observational study done in Institute of Medicine, Tribhuvan University Teaching Hospital, Department of Urology and Kidney Transplant Surgery. It was a retrospective study done on patients who visited Urology Department over 1 year from June 2020 to May 2021. Patients diagnosed as urinary stone disease who had high risk factors for stone recurrence were recruited for study. Detail medical and surgical history was retrieved from case sheet. Management modality applied to each individual patients was noted. Metabolic evaluation if done for those patients was recorded. This included basic metabolic evaluation including serum calcium, sodium, potassium, uric acid, phosphorus, Vitamin D, intact Parathyroid hormone (PTH), urine routine and microscopic examination and urine culture and sensitivity. Urinary evaluation was done when patient was rendered stone free or was free of any obstructing stone preferably after 20 days of operation. Serum and urinary evaluation was done with normal dietary pattern and fluid intake. Single 24-h urinary evaluation including urinary volume, citrate, calcium, phosphorus, sodium, potassium, uric acid, creatinine was also recorded.
24-h urine collection: This was done in specific plastic bottle provided by laboratory. On the first day of collection, first morning void was discarded and subsequent voiding was collected till first morning voiding of second day. Internal check of complete 24-h urine collection was done from total urinary creatinine level.
Urinary parameters were analyzed using different principles from a single laboratory. Normal reference values and method of analysis are shown in Table 1.
Stone analysis was performed in selected cases by Fourier transform Infrared Spectroscopy (FTIR) method.
Data were collected and entered in Microsoft Windows Excel. All statistical analyses were conducted in SPSS version 25. Continuous variables were expressed as mean ± SD. Categorical variables were expressed as percentage and proportions.
During 1 year of study period, sixty-five patients had undergone extensive metabolic evaluation, but complete data were available for only forty-six patients. Of the total patients (N = 46), 63% were male (n = 29) and rest (37%) were female (n = 17). Mean age of patients was 34.4 ± 15.1 years. Average BMI was 24.3 kg/m2. The average 24-h urine volume was 2400 ml. Clinical parameters of patient are shown in Table 2.
High-risk stone formers are those with multiple, bilateral, recurrent stones, children with stones, Hyperparathyroidism, patient with bowel resection or malabsorption syndrome, etc. In our study, common reasons for metabolic evaluation were multiple stones (40%), bilateral stones (27%), recurrent stones (17%) as shown in Table 3.
Co-morbidity associated with stone disease patients was as follows: Hypertension (54%), Diabetes mellitus (31%) and hypothyroidism (15%). Symptomatic stones were managed with different modalities. More than half of patients (53%) were managed with Retrograde intra-renal surgery (RIRS) followed by Percutaneous Nephrolithotomy (PCNL) (33%). Rest of the patient (13%) were managed with uretero-renoscopic lithotripsy (URSL) and very few (1%) with observation. Stone analysis data were available for twenty-five patients. Most common stone type was mixed stone with predominant composition being calcium oxalate (62.9%) as shown in Table 4.
Single 24-h urinary analysis was done for all patients at least 20 days after being stone free or rendered non-obstructing stone. Patients were advised for normal diet intake during evaluation. 24-h urinary metabolic evaluation showed hyper-oxaluria (32.6%) as most common abnormalities followed by hypocitraturia (21.7%) and hypocalciuria (21.7%) as shown in Table 5. One patient of each hypocitraturia and hypercalciuria was diagnosed as Distal RTA (Renal Tubular Acidosis) and hyperparathyroidism. About 23.91% of patients had more than one metabolic abnormalities.
Urinary stone disease is prevalent all around the world with increasing incidences with modernization [21, 22]. Treatment and management has changed from open operative procedures to minimal invasive and endoscopic procedures. There is growing concern and medical research in the field of prevention of urinary stone disease.
Dietary habits, obesity, increasing metabolic syndrome, Diabetes mellitus, different metabolic disorders have their part to share for the cause of increased stone disease [23,24,25]. Urinary stone disease can cause pain, infection, renal impairment and requires some form of treatment. In addition to it, stones may recur after some interval, adding misery and cost of treatment. It is prime duty of urologist to prevent such recurrences by investigating and identifying the cause of recurrences.
This study is first of its kind from our country to the best of our knowledge. In our study, we had younger group of patients (mean age 34.4 ± 15.1 vs. 52.1 ± 13.2) as compared to other studies [16, 17]. Our patients had higher 24-h urinary volume compared to another study (2400 ± 650 ml vs. 1719 ± 712 ml) . This could be because with diagnosis of stone disease, patient start drinking plenty of water.
Our study shows higher incidence of hyperoxaluria as compare to other studies [18,19,20] but lower incidence compared to study by Joshi et al. from India . This could be high consumption of diet rich in oxalates such as potato, green leafy vegetables like spinach, coffees, and oranges. This theory is further supported by report of highest per capita consumption of potato in our country (84 kg) compared to other neighboring countries like India (26 kg) and China (43.8 kg) . As compared to western studies, hypercalciuria (15.2%) was not so common in our study [18,19,20]. This could be because of dietary differences between developing countries versus developed countries with more amount of meat and calcium supplementation in food in latter countries.
Hypocitraturia is second most common abnormality detected on urinary analysis. Many other regional studies from south and east Asian countries have reported hypocitraturia as most common abnormality . Citrate is one of the important inhibiting factor for calcium crystallization. Hypocalciuria (21.7%) is another abnormality detected in our patients which is not reported in other studies. Hypocalciuria may be another reason resulting hyperoxaluria. Low calcium in diet increases oxalate absorption from intestines.
Mean 24 h urinary oxalate value of our study is higher than means of different studies. This could be because of different dietary habits, geographic, ethnic, genetic makeup and low dietary calcium consumption. Mean 24 h urinary calcium value from our study is comparable to studies from Asia, however, lower than studies from developed world. This could be due to lesser consumption of diet containing calcium like meat, cheese, dairy products, calcium and vitamin D supplements from our part of world. This may be one of reason for high oxalate value too because calcium chelates excess oxalate from bowel (Table 6).
Mean citrate value in our patient is lower than the values from western people but comparable to mean from Asian studies. We could not find any secondary causes of hypocitraturia in our patients. However, United Nations Food and Agricultural Organization (FAO) in 2017 published that south Asian countries had lower per capita citrus fruit consumption compared to developed countries (65.4 kg vs. 90 kg) . This may the reason for lower values for our patients (Table 7).
Important limitation of our study is its retrospective nature with possibilities of biases and relatively smaller number of patients. Based on our patients’ urinary profile, we recommend following for stone recurrence prevention.
Drinking plenty of water > 3 l/day as a part of general recommendation.
Consuming calcium rich diet and decreasing diet in oxalate.
As, this is a retrospective study, confirmation of the findings of this study need to be done by larger prospective study or randomized control trial to compare different dietary intervention to reduce stone recurrence in future.
Hyperoxaluria and hypocitraturia are the two most common metabolic urinary abnormalities in our patients. These findings help in counselling dietary measures to patients.
Availability of data and materials
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Renal tubular acidosis
American Urological Associations
Fourier transform infrared spectroscopy
Retrograde intrarenal surgery
Rule AD, Lieske JC, Li X, Melton LJ 3rd, Krambeck AE, Bergstralh EJ (2014) The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol 25(12):2878–2886
Vaughan LE, Enders FT, Lieske JC, Pais VM, Rivera ME, Mehta RA (2019) Predictors of symptomatic kidney stone recurrence after the first and subsequent episodes. Mayo Clin Proc 94(2):202–210
Sakhaee K, Maalouf NM, Kumar R, Pasch A, Moe OW (2011) Nephrolithiasis-associated bone disease: pathogenesis and treatment options. Kidney Int 79(4):393–403
Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17(3):304–309
Devarajan A (2018) Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases. Clin Sci (Lond) 132(6):615–626
Pak CY, Britton F, Peterson R et al (1980) Ambulatory evaluation of nephrolithiasis. Classification, clinical presentation and diagnostic criteria. Am J Med 69(1):19–30
Pak CY, Peterson RD, Poindexter J (2002) Prevention of spinal bone loss by potassium citrate in cases of calcium urolithiasis. J Urol 168(1):31–34
Pak CY, Poindexter JR, Adams-Huet B et al (2003) Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med 115(1):26–32
Pearle MS, Goldfarb DS, Assimos DG et al (2014) American Urological Association: medical management of kidney stones: AUA guideline. J Urol 192(2):316–324
Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M et al (2016) EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 69(3):468–474
Dion M, Ankawi G, Chew B, Paterson R, Sultan N, Hoddinott P et al (2016) CUA guideline on the evaluation and medical management of the kidney stone patient—2016 update. Can Urol Assoc J 10(11–12):E347–E358
Kumar J, Mandhani A et al (2013) Pediatric urolithiasis: experience from a tertiary referral center. J Pediatr Urol 9(6 Pt A):825–830
Gouru VR, Pogula VR, Vaddi SP, Manne V, Byram R, Kadiyala LS (2018) Metabolic evaluation of children with urolithiasis. Urol Ann 10(1):94–99
Chandhoke PS (2002) When is medical prophylaxis cost-effective for recurrent calcium stones? J Urol 168(3):937–940
Lotan Y, Cadeddu JA, Roerhborn CG et al (2004) Cost-effectiveness of medical management strategies for nephrolithiasis. J Urol 172(6 Pt 1):2275–2281
Joshi A, Gupta SK, Srivastava A (2013) Metabolic evaluation in first-time renal stone formers in North India: a single center study. Saudi J Kidney Dis Transpl 24(4):838–843
Hong YH, Dublin N, Razack AH, Mohd MA, Husain R (2012) Urinary metabolic evaluation of stone formers—a Malaysian perspective. Urology 80(3):529–534
Curhan GC, Willett WC, Speizer FE, Stampfer MJ (2001) Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59(6):2290–2298
Stitchantrakul W, Kochakarn W, Ruangraksa C, Domrongkitchaiporn S (2007) Urinary risk factors for recurrent calcium stone formation in Thai stone formers. J Med Assoc Thai 90(4):688–698
Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A (2005) The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol 173(5):1601–1605
Romero V, Akpinar H, Assimos DG (2010) Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol 12:e86–e96
Yasui T, Iguchi M, Suzuki S et al (2008) Prevalence and epidemiologic characteristics of urolithiasis in Japan: national trends between 1965 and 2005. Urology 71:209–213
Taylor EN, Curhan GC (2006) Body size and 24-hour urine composition. Am J Kidney Dis 48:905–915
Taylor EN, Stampfer MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235
Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462
Food and Agriculture Organization of the United Nations, faostat [ internet], Rome, ltaly, [updated on 5/29/2022], available at https://www.fao.org/faostat/en/#compare
We would like to thank all the patients, laboratory staffs for their help.
No external funding was available for this study.
Ethics approval and consent to participate
This study was conducted with approval of institutional review committee of Institute of Medicine, Tribhuvan University with approval number of 509 (6-11) E2 077/078. Informed written consent to participate in the study was provided by all participants or their parent or legal guardian in the case of children under age of 16.
Consent for publication
Written informed consent for the publication of details and images relating to individual participants was taken from all participants or their parent or legal guardian in the case of children under age of 16 as and when necessary.
Authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Parajuli, P., Luitel, B.R., Pradhan, M.M. et al. Metabolic evaluation of high-risk stone formers: a retrospective study. Afr J Urol 29, 6 (2023). https://doi.org/10.1186/s12301-023-00336-8
- Renal stone
- High-risk stone formers
- Metabolic abnormalities
- Metabolic evaluation